1. Approved Products
On the following pages various investment products are presented. The Swiss Federal Banking Commission has not granted permission for distribution in Switzerland for all of these products. Unless explicitly stated that a product has been granted permission for distribution in Switzerland, the product is not offered in Switzerland. The products that have been granted permission for distribution in Switzerland are not offered to residents of any country other than Switzerland.
Notice to Residents or Citizens of China, Japan, Singapore, U.K. and United States
Adamant Biomedical Investments AG has not been registered as an investment advisor and none of its products have been admitted for marketing or distribution by the competent financial authorities in China, Japan, Singapore, U.K. and United States and none of Adamant Biomedical Investments AG's services or products are offered in any of these countries, or their territories or other areas subject to their jurisdiction.
Disclaimer
2. No Offer and no Recommendation
The material on this website is not intended to and shall not in any way constitute an invitation or recommendation to invest in any of the investment products that appear or are mentioned.
Potential investors should note that investments in these products involve significant risks of a loss in value and that past performances can in no way predict the future performances of an investment product.
The material on this website is not intended to and shall not in any way constitute an invitation or recommendation to invest in any of the investment products that appear or are mentioned.
Potential investors should note that investments in these products involve significant risks of a loss in value and that past performances can in no way predict the future performances of an investment product.
3. Exclusion of Liability
In no event, including (without limitation) negligence, will Adamant Biomedical Investments AG or its affiliates be liable for any loss or damage of any kind, including (without limitation) any direct, indirect or consequential damages, arising out of or in connection with the use of this website or the link to other websites. The content of this website may be changed at any time.
In no event, including (without limitation) negligence, will Adamant Biomedical Investments AG or its affiliates be liable for any loss or damage of any kind, including (without limitation) any direct, indirect or consequential damages, arising out of or in connection with the use of this website or the link to other websites. The content of this website may be changed at any time.
News
Adamant Newsletter Juli 10
Mid-term review
Mid-term review
Adamant Newsletter Juni 10
Fight against cancer: More and more survive
Fight against cancer: More and more survive
Adamant Newsletter May 10
Growth in the pharma sector through 2009.
Growth in the pharma sector through 2009.
Adamant in the press
Cash June 10
Chinese healthcare reform seen through Swiss Medtech eyes
Chinese healthcare reform seen through Swiss Medtech eyes
EURO Finanzen May 10
How to profit from the Asian market - with the Lacuna Adamant Asia Pacific fund
How to profit from the Asian market - with the Lacuna Adamant Asia Pacific fund
Finanz und Wirtschaft Apr 10
Investors can profit from the growth in the diabetes sector
Investors can profit from the growth in the diabetes sector